← Open Payments lookup

DAWN RUSSI: Open Payments

NPI 1831549765 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$956 in 46 payments from 19 companies in 2025. Trend: 2023 $1,422 · 2024 $908 · 2025 $956

Food & beverage: $956
CompanyPaymentsAmount
Xeris Pharmaceuticals, Inc.6$128
Ascendis Pharma Endocrinology Inc5$114
Insulet Corporation4$109
Lilly USA, LLC5$107
Amgen Inc.3$55
Almatica Pharma LLC3$52
United Therapeutics Corporation2$51
Tandem Diabetes Care, Inc.3$50
Novo Nordisk Inc2$43
Boehringer Ingelheim Pharmaceuticals, Inc.2$38

Products named: GVOKE HYPOPEN, Yorvipath, Omnipod, MOUNJARO, EVENITY, TERIPARATIDE, Tyvaso, t:slim X2 Insulin Pump with Control-IQ.

Industry payments across FL — which companies pay providers there.